| CSA | Canadian Standards Association; canavaninosuccinic acid; carbonyl salicylamide; cell surface antigen... |
|---|---|
| CSMT | chorionic somatomammotropin |
| CVB | chorionic villi biopsy |
| CVS | cardiovascular surgery; cardiovascular system; challenge virus strain; chorionic villi sampling; cle... |
| TCB | tetrachlorobiphenyl; total cardiopulmonary bypass transcatheter biopsy; transabdominal chorionic bio... |
| herpes virus 4, human | A species of lymphocryptovirus cultivated from cultures of burkitt lymphoma. It is thought to be the causative agent of infectious mononucleosis. (12 Dec 1998) |
|---|---|
| herpes virus 6, human | The type species of roseolovirus isolated from patients with aids and other lymphoproliferative disorders. It infects and replicates in fresh and established lines of haematopoietic cells and cells of neural origin. It also appears to alter nk cell activity. Hhv-6 (hblv) antibodies are elevated in patients with aids, sjogren's syndrome, sarcoidosis, chronic fatigue syndrome, and certain malignancies. Hhv-6 is the cause of exanthema subitum and has been implicated in encephalitis. (12 Dec 1998) |
| herpes virus 7, human | A species of the family herpesviridae isolated from activated, CD4-positive T-lymphocytes taken from the blood of a healthy human. (12 Dec 1998) |
| human | Belonging to man or mankind; having the qualities or attributes of a man; of or pertaining to man or to the race of man; as, a human voice; human shape; human nature; human sacrifices. "To err is human; to forgive, divine." (Pope) Origin: L. Humanus; akin to homo man: cf. F. Humain. See Homage, and cf. Humane, Omber. Source: Websters Dictionary (01 Mar 1998) |
| human a1-proteinase inhibitor | A glycoprotein that is the major protease inhibitor of human serum, is synthesised in the liver, and is genetically polymorphic due to the presence of over 20 alleles; individuals appropriately homozygous are deficient in a1-trypsin and are predisposed to pulmonary emphysema and juvenile hepatic cirrhosis because of alterations in the amino acid and sialic acid components of the glycoprotein. A1-Antitrypsin also inhibits thrombin. Synonym: a1-trypsin inhibitor, human a1-proteinase inhibitor. (05 Mar 2000) |
| human activities | Activities performed by humans. (12 Dec 1998) |
| human antihemophilic factor | A lyophilised concentrate of factor VIII, obtained from fresh normal human plasma; used as a haemostatic agent in haemophilia. Synonym: antihemophilic globulin, human antihemophilic fraction. (05 Mar 2000) |
| human antihemophilic fraction | A lyophilised concentrate of factor VIII, obtained from fresh normal human plasma; used as a haemostatic agent in haemophilia. Synonym: antihemophilic globulin, human antihemophilic fraction. (05 Mar 2000) |
| human babesiosis | A rare human disease caused by infection with Babesia species (most frequently B. Divergens in Europe and B. Microti in the U.S.) that has been fatal in some splenectomised individuals. (05 Mar 2000) |
| human body | The human being as a non-anatomical and non-zoological entity. The emphasis is on the philosophical or artistic treatment of the human being, and includes lay and social attitudes toward the body in history. (12 Dec 1998) |
| human botfly | A large, blue, brown-winged species whose larvae develop in open boil-like lesions in the skin of humans, many domestic animals, and some fowl. It is a very serious and damaging cattle parasite and frequently attacks small children in Central and South America. Its eggs are laid on the legs or abdomen of another insect, such as the mosquito; the eggs later hatch, when stimulated by warmth or other factors, to release the botfly larvae on the skin of the mosquito's bloodmeal host, and the larvae quickly invade the skin to initiate myiasis. Synonym: Dermatobia cyaniventris, human botfly, skin botflies, warble botfly. (05 Mar 2000) |
| human botfly myiasis | Infection of man and animals with larvae of the fly Dermatobia hominis. Synonym: human botfly myiasis. (05 Mar 2000) |
| human clinical trial | <pharmacology> Controlled clinical studies in human volunteers to test the safety and efficacy of pharmaceutical candidates. There are usually three distinct phases of human clinical testing: Phases I, II, and III. Phase I trials are safety studies of volunteers, usually healthy controls. Phase II trials are studies to confirm safety and study optimum dose and initial efficacy. Phase III trials are studies to prove safety and efficacy in a specific patient population. (14 Nov 1997) |
| human cytomegalovirus | <virology> A group of viruses within the subfamily Cytomegalovirus (Betaherpesvirinae) (of the family Herpesviridae) which infects human beings. (09 Oct 1997) |
| human development | Continuous sequential changes which occur in the physiological and psychological functions during the individual's life. (12 Dec 1998) |